Pillstats
Rx only · Gel · Topical

Daspone

Brands: Dapsone · Dapsone

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD10AX05
RxCUI (US)3108
US makers1 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.280$0.560$0.841$1.12Dec 2025Apr 2026Jul 2026
$0.753
Latest avg · Jul 22, 2026
-23%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2074136208272025 Q12025 Q22025 Q32025 Q42026 Q1
57
Rx · 2026 Q1
4.2K
Units dispensed
-92%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 27, 2026
    RESOLVEDShortage resolved: Dapsone Gel (Amneal Pharmaceuticals)

    Dapsone Gel — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Dermatology.

  • Mar 27, 2026
    SHORTAGEDrug shortage: Dapsone Gel (Amneal Pharmaceuticals)

    Dapsone Gel — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Dermatology.